CR duration of patients who received the third course of postremission intensification therapy according to whether or not G-CSF was part of the regimen. There was no significant difference between the two groups (P = .54) with a median length of remission of 1.2 years for patients who did not receive the growth factor and 1.4 years for patients who did receive it.